Effects of High and Low Doses of Folic Acid on the Soluble Receptor Activator of Nuclear Factor-kappa B Ligand/Osteoprotegerin Ratio during Pregnancy

Effects of High and Low Doses of Folic Acid on the Soluble Receptor Activator of Nuclear Factor-kappa B Ligand/Osteoprotegerin Ratio during Pregnancy

Background: Pregnancy Associated Osteoporosis (PAO) can lead to serious difficulties such as fragility fractures, elongated back pain and height loss in affected women. Soluble Receptor Activator of Nuclear Factor-Kappa B ligand (sRANKL) to Osteoprotegerin (OPG) ratio is chosen as a bone metabolism...

Full description

Bibliographic Details
Main Authors: Nazila FATHI MAROUFI, Amir GHORBANIHAGHJO, Manizheh SAYYAH MELLI, Maryam VAEZI, Zohreh HEKMATI AZAR MEHRABANI, Maryam BANNAZADEH AMIRKHIZ, Nadereh RASHTCHIZADEH
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2017-04-01
Series:Iranian Journal of Public Health
Subjects:
Folic acid
Osteoprotegerin
Tumor necrosis factorα
Pregnancy
Online Access:https://ijph.tums.ac.ir/index.php/ijph/article/view/9760

Internet

https://ijph.tums.ac.ir/index.php/ijph/article/view/9760

Similar Items